S. А. Lukyanov

768 total citations
36 papers, 564 citations indexed

About

S. А. Lukyanov is a scholar working on Molecular Biology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. А. Lukyanov has authored 36 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. А. Lukyanov's work include COVID-19 Clinical Research Studies (5 papers), Neonatal Respiratory Health Research (5 papers) and Respiratory viral infections research (4 papers). S. А. Lukyanov is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Neonatal Respiratory Health Research (5 papers) and Respiratory viral infections research (4 papers). S. А. Lukyanov collaborates with scholars based in Russia, Israel and Austria. S. А. Lukyanov's co-authors include Yun‐Fai Chris Lau, Luda Diatchenko, Paul D. Siebert, Oleg A. Stremovskiy, Г. М. Прошкина, Petrov Rv, Anastasiya V. Ryabova, Sergey M. Deyev, Dmitriy B. Staroverov and Kseniya N. Markvicheva and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and FEBS Letters.

In The Last Decade

S. А. Lukyanov

31 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. А. Lukyanov Russia 6 287 110 78 59 45 36 564
Cédric Pionneau France 20 455 1.6× 194 1.8× 98 1.3× 90 1.5× 39 0.9× 39 913
Han Wu China 18 791 2.8× 94 0.9× 103 1.3× 95 1.6× 25 0.6× 57 1.2k
Beata Szymańska Poland 15 293 1.0× 32 0.3× 38 0.5× 121 2.1× 78 1.7× 50 613
Wenqin Xie United States 14 854 3.0× 80 0.7× 107 1.4× 109 1.8× 38 0.8× 31 1.2k
Shaobo Wu China 16 482 1.7× 60 0.5× 64 0.8× 139 2.4× 21 0.5× 68 843
Anuradha Mehta United States 13 561 2.0× 169 1.5× 68 0.9× 43 0.7× 23 0.5× 27 869
Daniela Maisel Germany 11 266 0.9× 47 0.4× 74 0.9× 56 0.9× 17 0.4× 13 487
Alexandra N. Bogomazova Russia 14 478 1.7× 43 0.4× 44 0.6× 83 1.4× 51 1.1× 71 771
John Nelson United Kingdom 17 408 1.4× 36 0.3× 82 1.1× 58 1.0× 82 1.8× 37 805

Countries citing papers authored by S. А. Lukyanov

Since Specialization
Citations

This map shows the geographic impact of S. А. Lukyanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. А. Lukyanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. А. Lukyanov more than expected).

Fields of papers citing papers by S. А. Lukyanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. А. Lukyanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. А. Lukyanov. The network helps show where S. А. Lukyanov may publish in the future.

Co-authorship network of co-authors of S. А. Lukyanov

This figure shows the co-authorship network connecting the top 25 collaborators of S. А. Lukyanov. A scholar is included among the top collaborators of S. А. Lukyanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. А. Lukyanov. S. А. Lukyanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Kuznik, et al.. (2022). [Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin.]. PubMed. 35(3). 368–374. 1 indexed citations
2.
Izraelson, Mark, Maria Metsger, Alexey N. Davydov, et al.. (2021). Distinct organization of adaptive immunity in the long-lived rodent Spalax galili. Nature Aging. 1(2). 179–189. 5 indexed citations
3.
Bi, Kuznik, et al.. (2021). The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19. Bulletin of Experimental Biology and Medicine. 171(4). 453–457. 1 indexed citations
4.
Lukyanov, S. А., et al.. (2021). The state of microcirculatory hemodynamics in patients with moderate and severe COVID-19. Bulletin of Experimental Biology and Medicine. 171(4). 463–468. 1 indexed citations
5.
6.
Bi, Kuznik, et al.. (2020). Effect of tocilizumab and thymalin on systemic inflammation in patients with COVID-19. Vrach. 31(11). 87–96. 2 indexed citations
7.
Lukyanov, S. А., et al.. (2020). The use of Thymaline to correct immune status deviations in COVID-19 (rationale for the use of drug and clinical case). Vrach. 31(8). 74–82. 5 indexed citations
8.
Lukyanov, S. А., et al.. (2019). SPECIFIC PARAMETERS OF RESPIRATORY SUPPORT IN SEVERE FORMS OF INFLUENZA A/H1N1/09 IN 2019. SHILAP Revista de lepidopterología. 16(3). 88–89. 2 indexed citations
9.
Lukyanov, S. А., et al.. (2019). Flu A(H1N1pdm09) and pneumonia: the burden of comorbidities (2009 vs 2019). PA2919–PA2919.
10.
Markvicheva, Kseniya N., Е. А. Богданова, Dmitriy B. Staroverov, S. А. Lukyanov, & Vsevolod V. Belousov. (2019). Imaging of Intracellular Hydrogen Peroxide Production with HyPer upon Stimulation of HeLa Cells with EGF. Methods in molecular biology. 85–91. 3 indexed citations
11.
Степанова, О. В., et al.. (2018). SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA. OA1922–OA1922. 1 indexed citations
12.
Lukyanov, S. А., et al.. (2015). Basic and clinical research in oncology: is there background for a breakthrough?. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Lukyanov, S. А., et al.. (2015). Changes in Heart Rhythm and Breathing in Acute Systemic Injury Due to Cold. General Reanimatology. 11(3). 16–16. 2 indexed citations
14.
Kudlаy, D.А., et al.. (2015). The Pharmacokinetic Properties, Safety and Tolerability of a New Nonacog Alfa (Innonafactor) in Patients with Hemophilia B. Blood. 126(23). 4691–4691. 1 indexed citations
15.
16.
Прошкина, Г. М., Anastasiya V. Ryabova, Oleg A. Stremovskiy, et al.. (2013). Genetically Encoded Immunophotosensitizer 4D5scFv-miniSOG is a Highly Selective Agent for Targeted Photokilling of Tumor Cells in Vitro. Theranostics. 3(11). 831–840. 70 indexed citations
17.
18.
Rutberg, Ph. G., et al.. (2011). Investigation of parameters of the three phase high-voltage alternating current plasma generator with power up to 100 kW working on steam. Journal of Physics Conference Series. 275. 12006–12006. 10 indexed citations
19.
Speer, Nicole K., et al.. (2004). Cloning and Analysis of a New Neurogene in the Mouse. Russian Journal of Genetics. 40(6). 694–697. 1 indexed citations
20.
Broude, Natalia E., Yuri B. Lebedev, Irving I. Gottesman, et al.. (1999). High polymorphism level of genomic sequences flanking insertion sites of human endogenous retroviral long terminal repeats. FEBS Letters. 443(3). 341–347. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cédric Pionneau Breakdown of academic impact, for papers by Han Wu Breakdown of academic impact, for papers by Beata Szymańska Breakdown of academic impact, for papers by Wenqin Xie Breakdown of academic impact, for papers by Shaobo Wu Breakdown of academic impact, for papers by Anuradha Mehta Breakdown of academic impact, for papers by Daniela Maisel Breakdown of academic impact, for papers by Alexandra N. Bogomazova Breakdown of academic impact, for papers by John Nelson
Rankless by CCL
2026